Evaluation of long term cardiotoxicity after epirubicin containing adjuvant chemotherapy and locoregional radiotherapy for breast cancer using various detection techniques.
Meinardi
M T
MT
Department of Medical Oncology, University Hospital Groningen, Groningen, Netherlands.
Van Der Graaf
W T A
WT
Gietema
J A
JA
Van Den Berg
M P
MP
Sleijfer
D T
DT
De Vries
E G E
EG
Haaksma
J
J
Boomsma
F
F
Van Veldhuisen
D J
DJ
D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D017024:Chemotherapy, Adjuvant; D002908:Chronic Disease; D003430:Cross-Sectional Studies; D003520:Cyclophosphamide / Q000008:administration & dosage; D004417:Dyspnea / Q000139:chemically induced; D015251:Epirubicin / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006331:Heart Diseases / Q000139:chemically induced*; D006801:Humans; D008134:Long-Term Care; D008875:Middle Aged
D000903:Antibiotics, Antineoplastic; D015251:Epirubicin; D003520:Cyclophosphamide; D005472:Fluorouracil